Advertisement ViraCor introduces new enterovirus test - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

ViraCor introduces new enterovirus test

ViraCor Laboratories has launched a new enterovirus test that quickly pinpoints the virus, which impacts 10-15 million Americans each year.

According to the company, the enterovirus molecular test quickly and accurately detects the more than 70 known strains of enterovirus, giving physicians the information they need to treat patients appropriately. It also allows them to determine and track the severity of an infection by measuring a patient’s viral load.

Steve Kleiboeker, chief scientific officer of ViraCor, said: “Enterovirus impacts millions of Americans each year, so we at ViraCor are very proud to give physicians the ability to get accurate test results in less than 24 hours. Our enterovirus testing service gives doctors the results they need for effective patient management.”